Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Accenture
Moodys
Harvard Business School
Cipla

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,782,406

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,782,406
Title:Kinase inhibitor and method for treatment of related diseases
Abstract: Disclosed is a compound of (aminophenylamino) pyrimidyl benzamides and a synthesis method thereof. The compound has Btk-inhibition activity and can be used to treat autoimmune diseases, heteroimmune diseases, cancers or thromboembolic diseases.
Inventor(s): Pan; Zhengying (Shenzhen, CN), Li; Xitao (Shenzhen, CN)
Assignee: Peking University Shenzhen Graduate School (Shenzhen, CN) Beijing Reciprocapharmaceuticals Co., Ltd. (Beijing, CN)
Application Number:14/830,128
Patent Claims:see list of patent claims

Details for Patent 9,782,406

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Peking University Shenzhen Graduate School (Shenzhen, CN) Beijing Reciprocapharmaceuticals Co., Ltd. (Beijing, CN) 2031-10-25 RX search
Bristol Myers Squibb ORENCIA abatacept INJECTABLE; IV (INFUSION) 125118 001 2005-12-23 ➤ Sign Up Peking University Shenzhen Graduate School (Shenzhen, CN) Beijing Reciprocapharmaceuticals Co., Ltd. (Beijing, CN) 2031-10-25 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Peking University Shenzhen Graduate School (Shenzhen, CN) Beijing Reciprocapharmaceuticals Co., Ltd. (Beijing, CN) 2031-10-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Colorcon
Moodys
McKesson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.